Compare Heron Therapeutics Inc (HRTX) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Heron Therapeutics Inc trades at $0.41 (market cap $68.01M), while Direxion Daily TSLA Bull 2X Shares trades at $10.4 (market cap $3.97B). The key difference: Direxion Daily TSLA Bull 2X Shares is far larger — about 58.4× Heron Therapeutics Inc's market cap, and Direxion Daily TSLA Bull 2X Shares is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Direxion Daily TSLA Bull 2X Shares for 15 Days on average.
| HRTX | TSLL | |
|---|---|---|
Market Cap | $68.01M | $3.97B |
Volume | 1,891,941 | 38,458,237 |
Sector | Health | Leveraged / Inverse |
52-Week High | $1.49 | $23.03 |
52-Week Low | $0.27 | $6.74 |
Typical Hold Time | 35 Days | 15 Days |
Enterprise Value | $174.75M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) trades at $0.36, down 8.15% today, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst sentiment remains overwhelmingly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings call discussions.
HRTX presents a high-risk opportunity with strong analyst support but fundamental challenges. The bullish technical setup and institutional confidence contrast with persistent losses and negative cash flow from operations. Investors face upside from potential operational improvements against the risk of continued financial underperformance in the competitive biotech sector.
TSLL, the Direxion Daily TSLA Bull 2X Shares ETF, trades at $10.01, down 1.38% on the day, with a neutral technical signal overall. Recent news highlights its sensitivity to Tesla's volatility, including an 11% rally tied to Cybercab hype (Benzinga, 2026-09-03). Key support and resistance levels cluster around $10, with the RSI_6 at 79.53 indicating potential overbought conditions. Financial ratios are not applicable as this is a leveraged ETF tracking Tesla's daily performance.
The outlook for TSLL is directly tied to Tesla's stock movements, offering amplified gains but heightened risk from daily rebalancing. Investment opportunity exists for short-term traders betting on Tesla's momentum, yet risks include decay from volatility and dependence on a single stock's performance. Caution is advised due to the product's complex nature and potential for significant losses even when Tesla rises modestly over time.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
